bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.10.26.564193

Distinguishing between- from within-site phase-amplitude coupling using antisymmetrized bispectra

Abstract

Phase-amplitude coupling (PAC) is a form of cross-frequency coupling in which the amplitude of a fast oscillation is locked to the phase of a slow oscillation. PAC has been proposed as a mechanism for integrating slow large-scale networks with fast-oscillating local processes in the brain. On a signal level, PAC can be observed in single time series, reflecting local dynamics, or between two time series, potentially reflecting a functional interaction between distinct brain sites. To investigate the role of PAC as a mechanism of brain signalling, it is important to distinguish these two cases. However, when mixtures of underlying signals are observed, between-site PAC can spuriously emerge even if the true interaction is only local (within-site). This problem arises in electrophysiological recordings where mixing occurs due to volume conduction or the presence of a shared electrical reference. To address this problem, we propose to estimate PAC using the anti-symmetrized bispectrum (ASB-PAC). It has previously been shown that the cross-bispectrum can be used to measure PAC while efficiently sup-pressing Gaussian noise, and that the anti-symmetrized bispectra vanish for mixtures of independent sources. However, ASB-PAC has so far not been used to assess the presence of genuine between-site PAC. Using simulations, we here investigate the performance of different algorithms to detect PAC in a mixed signal setting as well as the performance of the same methods to distinguish genuine between-site PAC from within-site PAC. This is done in a minimal two-channel setup as well as in a more complex setting that assesses PAC on reconstructions of simulated EEG sources. We observe that bispectral PAC methods are considerably better at detecting simulated PAC in the volume conduction setting than three conventional PAC estimators. ASB-PAC achieves the highest performance in detecting genuine between-site PAC interactions while detecting the fewest spurious interactions. Using the ASB-PAC could therefore greatly facilitate the interpretation of future PAC studies when discriminating local from remote effects. We demonstrate the application of ASB-PAC on EEG data from a motor imagery experiment. Additionally, we present an upgraded version of the free ROIconnect plugin for the EEGLAB toolbox, which includes PAC and ASB-PAC metriscs based on bispectra.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Pellegrini, F., Nguyen, T. D., Herrera, T., Nikulin, V., Nolte, G., Haufe, S.. 2023-10-30. Distinguishing between- from within-site phase-amplitude coupling using antisymmetrized bispectra. https://doi.org/10.1101/2023.10.26.564193

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗